100 related articles for article (PubMed ID: 27582550)
21. Emerging role of miR-320a in lung cancer: a comprehensive review.
Mohanta A; Kumar RR; Singh RK; Mandal S; Yadav R; Khatkar R; Sharma U; Uttam V; Rana MK; Rana AP; Jain A
Biomark Med; 2023 Sep; 17(18):767-781. PubMed ID: 38095986
[TBL] [Abstract][Full Text] [Related]
22. High glucose enhances the metastatic potential of tongue squamous cell carcinoma via the PKM2 pathway.
Wang W; He Q; Yan W; Sun J; Chen Z; Liu Z; Lu Z; Hou J; Shao Y; Zhou X; Wang A
Oncotarget; 2017 Dec; 8(67):111770-111779. PubMed ID: 29340090
[TBL] [Abstract][Full Text] [Related]
23. Correction for: MiR-320a induces diabetic nephropathy via inhibiting MafB.
He M; Wang J; Yin Z; Zhao Y; Hou H; Fan J; Li H; Wen Z; Tang J; Wang Y; Wang DW; Chen C
Aging (Albany NY); 2022 Dec; 14(23):9773-9774. PubMed ID: 36521050
[No Abstract] [Full Text] [Related]
24. MicroRNA expression as a prognostic biomarker of tongue squamous cell carcinoma (TSCC): a systematic review and meta-analysis.
Sun Y; Li Y; Zhou W; Liu Z
BMC Oral Health; 2024 Mar; 24(1):406. PubMed ID: 38556858
[TBL] [Abstract][Full Text] [Related]
25. CYTOR Facilitates Formation of FOSL1 Phase Separation and Super Enhancers to Drive Metastasis of Tumor Budding Cells in Head and Neck Squamous Cell Carcinoma.
Wang W; Yun B; Hoyle RG; Ma Z; Zaman SU; Xiong G; Yi C; Xie N; Zhang M; Liu X; Bandyopadhyay D; Li J; Wang C
Adv Sci (Weinh); 2024 Jan; 11(4):e2305002. PubMed ID: 38032139
[TBL] [Abstract][Full Text] [Related]
26. Tumor budding as a potential prognostic marker in determining the behavior of primary liver cancers.
Unal B; Celik MY; Gedik EO; Bassorgun CI; Elpek GO
World J Hepatol; 2023 Jun; 15(6):775-785. PubMed ID: 37397937
[TBL] [Abstract][Full Text] [Related]
27. Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy.
Roi A; Boia S; Rusu LC; Roi CI; Boia ER; Riviș M
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979943
[TBL] [Abstract][Full Text] [Related]
28. Relationship between Tumor Budding and Partial Epithelial-Mesenchymal Transition in Head and Neck Cancer.
Okuyama K; Suzuki K; Yanamoto S
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831453
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy.
Liang Y; Li S; Tang L
Biomedicines; 2021 May; 9(6):. PubMed ID: 34071109
[TBL] [Abstract][Full Text] [Related]
30. A Super-Enhancer Driven by FOSL1 Controls miR-21-5p Expression in Head and Neck Squamous Cell Carcinoma.
Wan Y; Hoyle RG; Xie N; Wang W; Cai H; Zhang M; Ma Z; Xiong G; Xu X; Huang Z; Liu X; Li J; Wang C
Front Oncol; 2021; 11():656628. PubMed ID: 33937067
[TBL] [Abstract][Full Text] [Related]
31. microRNAs Mediated Regulation of the Ribosomal Proteins and its Consequences on the Global Translation of Proteins.
Reza AMMT; Yuan YG
Cells; 2021 Jan; 10(1):. PubMed ID: 33435549
[TBL] [Abstract][Full Text] [Related]
32. The Emerging Role of MicroRNAs in Regulating the Drug Response of Cholangiocarcinoma.
Huang WK; Yeh CN
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 33007962
[TBL] [Abstract][Full Text] [Related]
33. Tumour budding in solid cancers.
Lugli A; Zlobec I; Berger MD; Kirsch R; Nagtegaal ID
Nat Rev Clin Oncol; 2021 Feb; 18(2):101-115. PubMed ID: 32901132
[TBL] [Abstract][Full Text] [Related]
34. Exosomal MicroRNA-320a Derived From Mesenchymal Stem Cells Regulates Rheumatoid Arthritis Fibroblast-Like Synoviocyte Activation by Suppressing CXCL9 Expression.
Meng Q; Qiu B
Front Physiol; 2020; 11():441. PubMed ID: 32528301
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma.
Zhuang Z; Yu P; Xie N; Wu Y; Liu H; Zhang M; Tao Y; Wang W; Yin H; Zou B; Hou J; Liu X; Li J; Huang H; Wang C
Theranostics; 2020; 10(3):1433-1453. PubMed ID: 31938073
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation.
Li YS; Zou Y; Dai DQ
World J Gastrointest Oncol; 2019 Oct; 11(10):842-856. PubMed ID: 31662823
[TBL] [Abstract][Full Text] [Related]
37. ΔNp63α suppresses cells invasion by downregulating PKCγ/Rac1 signaling through miR-320a.
Aljagthmi AA; Hill NT; Cooke M; Kazanietz MG; Abba MC; Long W; Kadakia MP
Cell Death Dis; 2019 Sep; 10(9):680. PubMed ID: 31515469
[TBL] [Abstract][Full Text] [Related]
38. Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
Zhu Y; Mohamed ASR; Lai SY; Yang S; Kanwar A; Wei L; Kamal M; Sengupta S; Elhalawani H; Skinner H; Mackin DS; Shiao J; Messer J; Wong A; Ding Y; Zhang L; Court L; Ji Y; Fuller CD
JCO Clin Cancer Inform; 2019 Feb; 3():1-9. PubMed ID: 30730765
[TBL] [Abstract][Full Text] [Related]
39. Invasion-Related Factors as Potential Diagnostic and Therapeutic Targets in Oral Squamous Cell Carcinoma-A Review.
Siriwardena SBSM; Tsunematsu T; Qi G; Ishimaru N; Kudo Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29758011
[TBL] [Abstract][Full Text] [Related]
40. Tumour budding in oral squamous cell carcinoma: a meta-analysis.
Almangush A; Pirinen M; Heikkinen I; Mäkitie AA; Salo T; Leivo I
Br J Cancer; 2018 Feb; 118(4):577-586. PubMed ID: 29190636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
